businesspress24.com - Medivation Announces Third Quarter Financial Results Teleconference and Webcast on November 9, 2011
 

Medivation Announces Third Quarter Financial Results Teleconference and Webcast on November 9, 2011

ID: 1052380

(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 11/02/11 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a teleconference and webcast with management to discuss third quarter financial results and provide a general business update on Wednesday, November 9, 2011 at 4:30 p.m. Eastern Time. A press release for the third quarter ended on September 30, 2011 will be released after markets close on November 9, 2011.

Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals interested in listening to the live call via webcast may do so by visiting the "Events and Presentations" page of the "Investor Relations" section of the Company's website at . A replay also will be available for 30 days following the live presentation.

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Astellas and Pfizer, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer and mild-to-moderate Alzheimer's disease. For more information, please visit us at .



Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Investor Relations
(650) 218-6900




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Threshold Pharmaceuticals Appoints Nipun Davar as Vice President of Pharmaceutical Development and Manufacturing
Marina Biotech Demonstrates That Its Novel UsiRNA Oligonucleotide Abrogates Cytotoxicity Resulting From microRNA-Like Off-Target Activity
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 02.11.2011 - 06:00 Uhr
Sprache: Deutsch
News-ID 1052380
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SAN FRANCISCO, CA


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 86 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Medivation Announces Third Quarter Financial Results Teleconference and Webcast on November 9, 2011
"
steht unter der journalistisch-redaktionellen Verantwortung von

Medivation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Medivation



 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 91


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.